| Lexicon Says IBS Drug Met Mid-Stage Study Goal |
|
Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial. The company said patients who took 1,000... More »
|
|
ABC News - Nov. 13, 2009
|
| Lexicon shares climb on trial results |
|
Shares of Lexicon Pharmaceuticals Inc. moved higher in early trading Friday on the news that one of its drugs achieved positive trial results. The Woodlands-based company... More »
|
|
Houston Business Journal - Nov. 13, 2009
|
| Lexicon says IBS drug met mid-stage study goal |
|
Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial. The company said patients who took 1,000... More »
|
|
Lexington Herald Leader - Nov. 13, 2009
|
| Positive results from Lexicon Pharmaceuticals' LX1031 Phase... |
|
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that the company's investigational new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated... More »
|
|
News-Medical.Net - Nov. 12, 2009
|
| Lexicon says IBS drug met mid-stage study goal |
|
Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial. The company said patients who took 1,000... More »
|
|
Lancaster Online - Nov. 13, 2009
|
| Lexicon Announces Positive Phase 2 Results of LX1031 in... |
|
THE WOODLANDS, Texas, Nov. 12 /PRNewswire-FirstCall/ -- (Nasdaq: LXRX) announced today that the company's investigational new drug, LX1031, a tryptophan hydroxylase (TPH)... More »
|
|
Red Orbit - Nov. 12, 2009
|
| Lexicon's Irritable Bowel Syndrome Drug LX1031 Shows... |
|
(RTTNews) - Developmental stage pharma company Lexicon Pharmaceuticals, Inc. (LXRX: News ), Thursday reported positive Phase II results evaluating LX1031, the company's... More »
|
|
RTTNews.com - Nov. 12, 2009
|
| Lexicon Announces Positive Phase 2 Results of LX1031 in... |
|
Companies mentioned in this article: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Nov. 12 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX)... More »
|
|
Freshnews.com - Nov. 12, 2009
|